Holder plans to sell 639,783 shares of VET (NYSE: VET)

Rhea-AI Filing Summary

A holder of NYSE-listed VET common stock has filed to potentially sell up to 639,783 shares through Fidelity Brokerage Services LLC. The securities are listed for sale as of 07/24/2026. The position includes shares acquired via stock awards, dividend-related issuances, and an earlier open market purchase.

Key Figures

Planned sale volume: 639783.00 shares Indicated market value: 152949630 Sale date reference: 07/24/2026 +5 more

8 metrics

Planned sale volume 639783.00 shares Common shares of VET to be sold on NYSE

Indicated market value 152949630 Aggregate value associated with 639,783 common shares

Sale date reference 07/24/2026 Date tied to the planned sale of common shares

Stock award acquisition 30367 shares Common shares from Stock Award dated 06/01/2026

Additional stock award 15017 shares Common shares from Stock Award dated 06/01/2026

Open market purchase 10750 shares Common shares purchased on 12/13/2021 for cash

Dividend acquisition 2026-07-01 96 shares Common shares acquired via DIVIDEND in cash on 07/01/2026

Dividend acquisition 2025-10-16 114 shares Common shares acquired via DIVIDEND in cash on 10/16/2025

Key Terms

Form 144, Stock Award, Open Market Purchase, DIVIDEND

4 terms

Form 144 regulatory

"144: Filer Information 144: Issuer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Award financial

"Common | 06/01/2026 | Stock Award | Issuer"

Open Market Purchase financial

"Common | 12/13/2021 | Open Market Purchase | Open Market"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

DIVIDEND financial

"Common | 07/01/2026 | DIVIDEND | Open Market"

A dividend is a payment that a company gives to its shareholders, usually from its profits. It’s like a bonus or reward for owning the company's stock, and it can provide a steady income stream for investors. Companies pay dividends to share their success with the people who own their stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/24/2026 - 03:31 PM Accepted by SEC EDGAR 07/24/2026 - 03:31 PM Learn about SEC filing dates

FAQ

What volume of VET common shares is planned for sale in this Form 144?

The filing contemplates a potential sale of up to 639,783 VET common shares. These shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, subject to market conditions and applicable rules.

What is the approximate market value of the VET shares covered by this Form 144?

The shares covered by the contemplated sale have an indicated aggregate market value of 152,949,630. This figure reflects the value associated with the 639,783 VET common shares listed in the filing.

When may the sale of VET shares disclosed in the Form 144 occur?

The Form 144 identifies 07/24/2026 in connection with the sale of the VET common shares. This date anchors the timing of the planned disposition, consistent with the form’s notice requirements.

How were the VET shares in the Form 144 originally acquired?

The filing shows the shares were acquired through stock awards on 06/01/2026, multiple DIVIDEND-related acquisitions between 2025 and 2026, and an open market purchase of 10,750 shares on 12/13/2021.

Which broker is listed for the planned VET share sale?

The planned sale of VET common shares is associated with Fidelity Brokerage Services LLC, located at 245 Summer Street, Boston, MA 02110. The shares are noted as trading on the NYSE.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	56518	639783.00	152949630	07/24/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Stock Award	Issuer			30367	06/01/2026	Compensation
Common	06/01/2026	Stock Award	Issuer			15017	06/01/2026	Compensation
Common	07/01/2026	DIVIDEND	Open Market			96	07/01/2026	CASH
Common	04/01/2026	DIVIDEND	Open Market			69	04/01/2026	CASH
Common	01/02/2026	DIVIDEND	Open Market			104	01/02/2026	CASH
Common	10/16/2025	DIVIDEND	Open Market			114	10/16/2025	CASH
Common	12/13/2021	Open Market Purchase	Open Market			10750	12/13/2021	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)